JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
154 hedge funds and large institutions have $2.54B invested in Juno Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 55 increasing their positions, 23 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
60% less call options, than puts
Call options by funds: $20.3M | Put options by funds: $51.1M
Holders
154
Holding in Top 10
3
Calls
$20.3M
Puts
$51.1M
Top Buyers
| 1 | +$28.8M | |
| 2 | +$24.6M | |
| 3 | +$24M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$21.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.7M |
Top Sellers
| 1 | -$88.5M | |
| 2 | -$61.1M | |
| 3 | -$58.4M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$21.1M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$15M |